Surgical Innovations Group plc, together with its subsidiaries, engages in the design, manufacture, and export of medical products for use in laparoscopic and robotic minimally invasive surgery in the United Kingdom, Europe, the Asia Pacific, the United States, and internationally. The company operates through three segments: SI Brand, Original Equipment Manufacturer (OEM), and Distribution. It offers YelloPort Elite port access systems; YelloPort + Resposable port access systems; LogiCut, a disposable laparoscopic scissors; Logic, a reusable laparoscopic grasping forceps and dissectors; LogiFlex, a dual purpose, Resposable device for blunt dissection and gastric band retrieval; FastClamp, a reusable laparoscopic clamping system, designed to fixate a range of instrumentation in position during minimally invasive surgery; PretzelFlex, a pretzel shaped organ and tissue retractor, designed for use in minimally invasive surgery; and LogiTube, a calibration tubing for gastric pouch sizing during sleeve gastrectomy, mini gastric bypass/one-anastomosis gastric bypass, or revision surgery for these procedures. The company also researches, develops, manufactures, and distributes minimally invasive devices for third party medical device companies through either own label or co-branding; minimally invasive technology products for precision engineering applications; and services for design and building of instruments. In addition, it distributes specialist medical products; and designs and manufactures autologous blood products. The company sells its products through independent healthcare distributors, as well as its own label products through OEM relationships. The company was incorporated in 1988 and is headquartered in Leeds, the United Kingdom.
Metrics to compare | SUNU | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipSUNUPeersSector | |
---|---|---|---|---|
P/E Ratio | −3.4x | −2.1x | −0.5x | |
PEG Ratio | 0.01 | 0.01 | 0.00 | |
Price/Book | 0.8x | 1.6x | 2.6x | |
Price / LTM Sales | 0.6x | 3.8x | 3.2x | |
Upside (Analyst Target) | 159.5% | 39.5% | 42.7% | |
Fair Value Upside | Unlock | 17.3% | 5.8% | Unlock |